Literature DB >> 7002393

Direct antiglobulin reactions in Gambian children with P. falciparum malaria. III. Expression of IgG subclass determinants and genetic markers and association with anaemia.

C A Facer.   

Abstract

The IgG subclass and Gm allotype distribution of red cell-bound IgG molecules from Gambian children with past or present falciparum malaria has been determined. The results show that the antibody is polyclonal with some predominance of the IgG2 and IgG4 subclasses. A restriction towards IgG2 antibodies may indicate specificity for a schizont-derived antigen which is carbohydrate in nature. Not all the allotypes normally carried by the G3m(b) allele could be demonstrated on IgG3-sensitized cells, a finding which remains unexplained. Expression of G3m(10), (11) and (14) allotypes of the IgG3 molecule was noted. Sensitization of red cells with IgG1 molecules correlated with the presence of anaemia but red cells sensitized with IgG2, IgG3 or IgG4 usually came from children with haematological findings within the normal range for that population. The implications of the results are discussed with reference to the few reports on the subclass and Gm allotype of malaria-specific IgG.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002393      PMCID: PMC1536921     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Antigenic determinants on immunoglobulins of nonhuman primates.

Authors:  E van Loghem; S D Litwin
Journal:  Transplant Proc       Date:  1972-03       Impact factor: 1.066

2.  Allotype preference in human Rh antibodies.

Authors:  S D Litwin
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

3.  Immunoglobulin characteristics of antibodies to malarial S-antigens in man.

Authors:  R J Wilson; I A McGregor
Journal:  Immunology       Date:  1973-09       Impact factor: 7.397

4.  A critical study of the IgG subclasses of Rh anti-D antibodies formed in pregnancy and in immunized volunteers.

Authors:  M E Devey; D Voak
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

5.  The lymphocyte surface. I. Relation between Fc receptors, C'3 receptors and surface immunoglobulin.

Authors:  C R Parish; J A Hayward
Journal:  Proc R Soc Lond B Biol Sci       Date:  1974-08-27

6.  Quantitative method for determining human G allotype antigens (Gm). II. Differences in Gm gene expression for G1 and G3 H chains in sera.

Authors:  S D Litwin; S Balaban
Journal:  J Immunol       Date:  1972-04       Impact factor: 5.422

7.  The IgG subclasses of red cell antibodies and relationship to monocyte binding.

Authors:  N Abramson; P H Schur
Journal:  Blood       Date:  1972-10       Impact factor: 22.113

8.  Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man.

Authors:  A F LoBuglio; R S Cotran; J H Jandl
Journal:  Science       Date:  1967-12-22       Impact factor: 47.728

9.  Autoimmune haemolytic anaemias. IV. Biochemical studies of red cells from patients with autoimmune haemolytic anaemia with incomplete warm autoantibodies.

Authors:  C P Engelfriet; D Beckers; J J van Loghem
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  13 in total

1.  Mapping of the antigenic determinants of the T. cruzi kinetoplastid membrane protein-11. Identification of a linear epitope specifically recognized by human Chagasic sera.

Authors:  M C Thomas; M V Longobardo; E Carmelo; C Marañón; L Planelles; M E Patarroyo; C Alonso; M C López
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

2.  IgG subclass distribution in organ specific autoantibodies. The relationship to complement fixing ability.

Authors:  B M Dean; G F Bottazzo; A G Cudworth
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

3.  IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis.

Authors:  D R Jayne; A P Weetman; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

4.  Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.

Authors:  J A Martiney; B Sherry; C N Metz; M Espinoza; A S Ferrer; T Calandra; H E Broxmeyer; R Bucala
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Extensive immunoglobulin binding of Plasmodium falciparum-infected erythrocytes in a group of children with moderate anemia.

Authors:  C Scholander; J Carlson; P G Kremsner; M Wahlgren
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  When is a malaria immune complex not an immune complex?

Authors:  R J Pleass
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

7.  Antigen-specific influence of GM/KM allotypes on IgG isotypes and association of GM allotypes with susceptibility to Plasmodium falciparum malaria.

Authors:  Hayder A Giha; Amre Nasr; Nnaemeka C Iriemenam; David Arnot; Marita Troye-Blomberg; Thor G Theander; Klavs Berzins; Gehad ElGhazali; Janardan P Pandey
Journal:  Malar J       Date:  2009-12-22       Impact factor: 2.979

8.  Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii.

Authors:  W I White; C B Evans; D W Taylor
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Severe malaria in African adults living in a seasonal endemic area.

Authors:  J M Saïssy; M Vitris; B Diatta; J Kempf; F Adam; J L Sarthou
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

10.  Plasmodium falciparum malaria mimicking autoimmune hemolytic anemia during pregnancy.

Authors:  J Drouin; G Rock; E E Jolly
Journal:  Can Med Assoc J       Date:  1985-02-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.